Closing Bell: Fennec Pharmaceuticals Inc up on Tuesday (FRX)

Today during trading, shares of Fennec Pharmaceuticals Inc opened at $8.80 and closed at $8.80. It traded at a low of $8.80 to a high of $8.80.

The price gained 0.46% from the previous day's close of $8.76.

During the day across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.

Fennec Pharmaceuticals Inc traded under FRX on the Toronto Stock Exchange (TSX).

A total of 112 shares was traded during the last trading day, with total trades of 2, while having an average volume of 429 in the last five days.

Trading across the entire TSX saw 2,584 price advancers against 2,644 declines and 86 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, in the last 12 months, Fennec Pharmaceuticals Inc's shares have dipped -21.92 percent, while this year, they have reduced -41.95%.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $239.34 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Based on 6.00 analysts, Fennec Pharmaceuticals Inc gets an average recommendation of "Strong Buy" according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..